Buy Dexafort 50 ml Injection Online: The Definitive Veterinary Guide to Dual-Ester Corticosteroid Therapy, Anti-Inflammatory Pathways, and Large Animal Metabolic Management

In livestock production, equine medicine, and companion animal critical care, rapid and sustained control of severe acute inflammation is a frequent clinical necessity. Conditions such as non-infectious musculoskeletal disorders, acute allergic reactions, shock configurations, and bovine primary ketosis demand immediate therapeutic intervention to limit tissue damage, restore systemic metabolic balance, and maintain structural animal welfare.

Traditional single-ester dexamethasone injections present an operational trade-off: free dexamethasone sodium phosphate clears within 24 hours, requiring repeated daily handlings that elevate patient stress, while insoluble dexamethasone acetate takes days to reach a therapeutic threshold.

To overcome these timing limitations, veterinarians rely on engineered dual-action therapies. Dexafort 50 ml Injection (manufactured by MSD Animal Health / Intervet) is the gold standard in veterinary glucocorticoid therapy. Formulated as a high-purity sterile aqueous suspension, each milliliter combines an immediate-release ester (Dexamethasone Sodium Phosphate) with a slow-release, long-acting ester (Dexamethasone Phenylpropionate). This unique combination provides instant therapeutic action that remains active for up to 8 days from a single injection site.

This comprehensive reference manual details the molecular pharmacology, dual-release mechanisms, target livestock indications, and precise clinical administration guidelines for Dexafort 50 ml.

1. Molecular Pharmacology & Dual-Ester Kinetic Mechanisms

Dexafort functions as a powerful synthetic analogue of cortisol, delivering up to thirty times the anti-inflammatory potency of baseline hydrocortisone while exerting zero mineralocorticoid (salt-retaining) activity.

                            [Dexafort 50 ml Dose Administered]
                                            |
                         [Deep Intramuscular Depot Formation]
                                            |
                 -------------------------------------------------
                |                                                 |
     [Dexamethasone Sodium Phosphate]              [Dexamethasone Phenylpropionate]
          (Immediate Release)                            (Extended Release)
                |                                                 |
     (Rapid Vascular Dissociation)                  (Slow Enzymatic Ester Hydrolysis)
                |                                                 |
                v                                                 v
     [Peak Plasma Levels within 1 Hour]             [Sustained Release over 8 Days]
                |                                                 |
                 ------------------------> <----------------------
                                        |
                                        v
                    [Binds Intracellular Glucocorticoid Receptors]
                                        |
                   [Inhibits Phospholipase A2 & Cytokine Cascades]
                                        |
                    [Immediate & Long-Lasting Inflammatory Relief]

The Dual-Ester Release Advantage

The clinical performance of Dexafort is driven by the differing solubility profiles of its two active components:

• Immediate-Action Phase: Dexamethasone sodium phosphate is highly water-soluble. Upon injection, it enters the vascular network immediately, achieving peak therapeutic plasma concentrations within 60 minutes to halt acute hypersensitivity or inflammatory shock.

• Sustained-Action Phase: Dexamethasone phenylpropionate is highly lipid-soluble and remains at the injection site to form a micro-depot. Tissue enzymes gradually hydrolyze the phenylpropionate ester over several days, releasing free dexamethasone steadily into the bloodstream to provide continuous anti-inflammatory action for up to 8 days.

Cellular Mechanism of Action

Once free inside the cell, dexamethasone binds with high affinity to cytoplasmic glucocorticoid receptors. The receptor-steroid complex moves into the nucleus, altering DNA transcription:

• Lipocortin-1 Up-regulation: It increases the production of Lipocortin-1, which directly inhibits the enzyme phospholipase A2, blocking the creation of prostaglandins and leukotrienes.

• Cytokine Suppression: It suppresses the expression of major inflammatory cytokines, rapidly reducing local tissue swelling, heat, capillary permeability, and cellular pain.

2. Core Veterinary Clinical Applications

Dexafort 50 ml is a versatile, high-impact therapeutic tool across major livestock and equine sectors:

• Musculoskeletal and Articular Pathologies: Indicated for treating acute arthritis, bursitis, tendosynovitis, periadenitis, and traumatic lameness in horses and cattle.

• Bovine Primary Ketosis (Acetonemia): Exerts a strong hyperglycemic effect by stimulating gluconeogenesis in the liver, rapidly elevating blood glucose parameters within 24 to 48 hours.

• Dermatological & Allergic Management: Clears severe acute eczema, urticaria (hives), pruritus, and insect bite hypersensitivities in companion animals and equines.

• Induction of Parturition: Used in cattle during late gestation to safely induce calving when maternal health is compromised.

3. Recommended Administration and Livestock Dosing Protocols

Because Dexafort is an aqueous suspension containing insoluble micro-crystals, it must be handled following precise clinical standards.

Veterinary Dosage Reference Table

The table below outlines standard clinical dosing parameters for Dexafort 50 ml (containing 2 mg/mL total active dexamethasone base):

4. Clinical Safety, Contraindications, and Withdrawal Periods

• Infectious Pathogen Guard: Corticosteroids suppress localized immune responses. Never administer Dexafort to animals with active viral, fungal, or bacterial infections unless paired with an appropriate broad-spectrum antibiotic (such as Hemoflor Plus).

• Gestational Restrictions: Do not use in pregnant animals during the first two trimesters of gestation unless the clinical goal is the induction of abortion or premature labor. High-dose glucocorticoids can induce premature parturition or fetal abnormalities.

• Diabetic and Renal Caveats: Contraindicated in animals suffering from diabetes mellitus, active renal insufficiency, or chronic congestive heart failure.

Agricultural Food Safety Withdrawal Windows

To prevent steroid residues from entering the human food chain, adhere strictly to these withdrawal times:

5. Frequently Asked Questions (FAQ)

What makes Dexafort different from standard dexamethasone injections?

Standard injections contain only water-soluble dexamethasone phosphate, which clears the body within 24 hours. Dexafort is a dual-ester formula that pairs an immediate-release phase with an insoluble phenylpropionate ester, providing a therapeutic effect for up to 8 days from a single dose.

Can Dexafort be administered directly into a vein (IV)?

No. Dexafort is a suspension containing micro-crystals and must never be given intravenously. It is optimized strictly for intramuscular (IM) injection. Accidental IV injection can cause vascular blockages or acute shock.

How quickly will bovine ketosis resolve after a Dexafort injection?

Blood glucose levels rise significantly within 24 hours of administration due to stimulated liver gluconeogenesis. Visible clinical improvements, including restored appetite and increased milk yields, are typically observed within 48 hours.

Where can I buy genuine Dexafort 50 ml online?

You can securely purchase authentic, factory-sealed Dexafort 50 ml online directly through Global Vet Care. Every vial is handled within our temperature-monitored distribution center to guarantee full chemical stability and sterility upon delivery.

6. Secure Pharmaceutical Distribution from Global Vet Care

At Global Vet Care, we understand that high-precision glucocorticoids require exceptional storage controls. Every batch of Dexafort 50 ml is stored within our climate-controlled pharmaceutical facility between 15°C and 25°C, protected from direct sunlight, and shipped securely to maintain sterile product value.

Dexafort 50 ml is a hormonal drug. It is used to treat inflammatory processes and diseases that have allergic and autoimmune etiology. Dexafort is a synthetic analogue of cortisone. As an active substance, 1 ml of the drug contains 2.67 mg. dexamethasone finylpropionate and 1.32 mg. dexamethasone sodium phosphate.

Dexafort has anti-inflammatory, anti-edematous, anti-allergic, desensitizing effect. The mechanism of action is to inhibit the release of inflammatory mediators by eosinophils and mast cells. Dexamethasone acts at all stages of the inflammatory process, increases the resistance of the cell membrane to various damaging factors. Dexafort stimulates steroid lymphocyte receptors, promoting the formation of lipocortins, which have anti-edematous effect. Inhibits the proliferation of lymphoid tissue and cellular immunity, disrupts the kinetics of T – lymphocytes, reduces their cytotoxic activity. The drug has a rapid and prolonged effect.

Action:

The drug is administered intramuscularly. The maximum concentration in blood plasma is reached in 60 minutes after administration. Therapeutic concentration in blood plasma is maintained for 30-96 hours, depending on the species. Bioavailability when administered intramuscularly is 100%.

Appointment:

– for the treatment of inflammatory diseases

– allergic dermatitis

– eczema

– post-traumatic edema

– bronchial asthma

– diseases of the joints

– acute mastitis.

Dosage and method of application:

Cattle and horses – 10 ml / once

Goats, pigs, foals – 1-3 ml / once

Dogs – 0.5-1 ml / once

Cats – 0.2.5-5 ml / once

If necessary, the drug is used again after 7 days.

Side effects:

– increased urination

– insatiable thirst

– excessive consumption of food

– with prolonged use, Cushing’s syndrome may occur

– the use of corticosteroids to stimulate childbirth reduces the viability of the fetus.

Contraindications: Hypersensitivity to the components of the drug. It is forbidden to use in the last trimester to pregnant females, as it can lead to premature birth and abortion. Do not use in animals with viral and fungal diseases, diabetes, osteoporosis, kidney disease and heart failure. With special care to enter animals in the first and second trimesters.

Special instructions: dairy products are forbidden to use 5 days after administration of Dexafort, meat products are allowed to be eaten in 48 hours.

Storage conditions: store out of reach of children and animals, separately from food at a temperature of 15-25 C. Shelf life 5 years from the date of manufacture. After opening, the bottle is suitable for 8 weeks.